With markets watching a softer May jobs report, muted hiring, elevated layoffs, and a Federal Reserve that may be reluctant to shift rates quickly, many investors are taking a fresh look at stocks that could hold up when growth feels less certain. This article focuses on three stocks from a Defensive Sectors screener, all from Utilities, Consumer Staples, and Healthcare, that are directly exposed to the latest labor market news. Each has been selected for financial strength within its sector, and the sections ahead explain how the current macro backdrop could matter for these companies.

Alignment Healthcare (ALHC)

Overview: Alignment Healthcare runs a consumer focused Medicare Advantage platform for seniors in the United States, using technology enabled care coordination and concierge style support to manage members’ health plans. Founded in 2013 and based in Orange, California, the company focuses on delivering tailored benefits and medical support within government backed insurance programs.

Operations: Alignment Healthcare generates about US$4.3b in revenue from providing healthcare services to Medicare Advantage members in the United States.

Market Cap: US$4.8b

Alignment Healthcare stands out in a slower growth jobs market because demand for senior healthcare tends to be more resilient. The company is combining that with strong revenue and earnings momentum, improving profitability and a focus on technology driven cost control. Recent results show expanding Medicare Advantage membership, positive net income and upgraded guidance, which supports the bullish analyst view and a valuation that some models suggest is below estimated fair value. At the same time, heavy reliance on Medicare Advantage rules, use of external borrowing and regulatory scrutiny around benefits and star ratings add real risk. For investors weighing defensive healthcare exposure with growth potential, the full story behind Alignment Healthcare’s margins, cash flow and regulatory exposure is critical.

Alignment Healthcare’s rapid Medicare Advantage momentum and tech driven cost control raise a clear question for investors: how does the full risk reward profile look when you line up margins, cash flow and regulation against the 4 key rewards and 1 important warning sign

Axogen (AXGN)

Overview: Axogen focuses on peripheral nerve repair, supplying surgeons with biologic grafts, connectors, and protective wraps that are used to restore nerve function after trauma or surgery in areas like the hand, face, and breast.

Operations: Axogen generates about US$238.1m in revenue from peripheral nerve repair products, all currently sourced from the United States.

Market Cap: US$2.4b

Axogen stands out in healthcare because its products target serious nerve injuries that patients cannot postpone, which can look appealing when a softer jobs market and elevated layoffs make more cyclical procedures vulnerable. The company is focused on expanding adoption of its nerve repair solutions, backed by improving payer coverage and a detailed clinical evidence base, but it is still unprofitable and carries funding risk from reliance on external borrowing. The company has issued guidance for at least 20% revenue growth in 2026 and a high gross margin range of 74% to 76%, while concentration in its Avance Nerve Graft portfolio, regulatory outcomes, and recent insider selling are key issues investors may want to weigh carefully.

Axogen’s efforts to expand adoption in essential nerve repair, supported by payer coverage and its clinical evidence base, raise an important question: how far this growth story can reasonably stretch when weighed against the analyst forecasts for Axogen

LifeStance Health Group (LFST)

Overview: LifeStance Health Group provides outpatient mental health care across the United States, offering therapy, psychiatric services, and psychological testing for children, adolescents, adults, and older patients. Care is delivered both virtually and through in person centers, covering conditions such as anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post traumatic stress disorder.

Operations: LifeStance Health Group generates about US$1.5b in revenue from mental health services in the United States.

Market Cap: US$4.0b

LifeStance Health Group may appeal to some investors in a softer jobs market because mental health services are often viewed as essential rather than discretionary. The company already operates at scale with about US$1.5b in revenue, recent profitability, and upgraded 2026 guidance. At the same time, the stock appears expensive on cash flow and price to sales metrics, and the business relies on external borrowing and continued access to capital, which can be important when layoffs are elevated and the Federal Reserve is cautious about cutting rates quickly.

There are additional factors that some investors may weigh. These include strong demand for therapy supported by outcomes data, index inclusion, and recent equity raising and buybacks. However, there are also risks around competition, reimbursement, and clinician capacity. Investors who focus on defensive growth characteristics may wish to take a closer look at LifeStance to better understand both the potential opportunities and the key risks.

LifeStance Health Group’s scale, recent profitability and upgraded 2026 guidance hint that the real story sits in the expectations baked into the analyst forecasts for LifeStance Health Group, as well as one underappreciated pressure point that could change the picture suddenly

The three stocks covered here are only a starting point, as the full Defensive Sectors (Utilities, Consumer Staples, Healthcare) screener surfaced 19 more companies with equally compelling stories across Utilities, Consumer Staples, and Healthcare. Identify and analyze the specific catalysts, balance sheet strength, and earnings narratives that matter most to you so you can focus on the highest conviction ideas in this defensive theme.

Take Control of Your Investment Journey

If LifeStance Health Group or any of these companies sound like a great opportunity, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value the ideal entry point. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Alternatives Before Others Catch On

Fresh stocks can move from quiet to flying once momentum builds, and that shift often happens before the crowd notices. Scan under the radar for now and act early.

• Track cash rich companies that hold up when sentiment drops by running the list of solid balance sheet and fundamentals (48 results) and see which stocks still look resilient while it matters.
• Target companies already generating real profits from AI by using the 61 profitable AI stocks that aren't just burning cash and focus on businesses where growth meets disciplined capital use.
• Spot infrastructure plays related to long term demand for electricity and data by reviewing the 35 power grid technology and infrastructure stocks before potential momentum becomes widely recognized.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.